Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study. (Q50726042)

From Wikidata
Jump to navigation Jump to search
scientific article published in August 2006
edit
Language Label Description Also known as
English
Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study.
scientific article published in August 2006

    Statements

    Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study. (English)
    Groupe Ouest-Est Leucémies et Maladies du Sang (GOELAMS)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit